Connor, Clark & Lunn Investment Management Ltd. Prothena Corp Public LTD CO Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $22 Billion
  • Q2 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 112,826 shares of PRTA stock, worth $2.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
112,826
Previous 131,905 14.46%
Holding current value
$2.26 Million
Previous $3.27 Million 28.74%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$19.54 - $26.15 $372,803 - $498,915
-19,079 Reduced 14.46%
112,826 $2.33 Million
Q1 2024

May 09, 2024
SELL
$24.75 - $40.66 $594,915 - $977,344
-24,037 Reduced 15.41%
131,905 $3.27 Million
Q4 2023

Feb 09, 2024
BUY
$32.31 - $52.32 $910,075 - $1.47 Million
28,167 Added 22.04%
155,942 $5.67 Million
Q3 2023

Nov 13, 2023
BUY
$47.3 - $70.6 $834,324 - $1.25 Million
17,639 Added 16.02%
127,775 $6.17 Million
Q2 2023

Aug 10, 2023
BUY
$48.26 - $78.59 $999,561 - $1.63 Million
20,712 Added 23.16%
110,136 $7.52 Million
Q1 2023

May 09, 2023
BUY
$46.97 - $58.27 $1.36 Million - $1.69 Million
28,992 Added 47.97%
89,424 $4.33 Million
Q4 2022

Feb 10, 2023
BUY
$52.05 - $65.0 $1.71 Million - $2.14 Million
32,876 Added 119.31%
60,432 $3.64 Million
Q3 2022

Nov 10, 2022
BUY
$25.16 - $60.63 $289,994 - $698,821
11,526 Added 71.9%
27,556 $1.67 Million
Q2 2022

Aug 05, 2022
BUY
$22.73 - $39.98 $364,361 - $640,879
16,030 New
16,030 $435,000
Q4 2021

Feb 10, 2022
SELL
$42.11 - $73.26 $281,715 - $490,109
-6,690 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$48.2 - $78.89 $322,458 - $527,774
6,690 New
6,690 $477,000
Q2 2020

Aug 13, 2020
SELL
$9.56 - $12.51 $250,711 - $328,074
-26,225 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$7.54 - $15.77 $45,994 - $96,197
6,100 Added 30.31%
26,225 $280,000
Q4 2019

Feb 12, 2020
SELL
$7.48 - $17.01 $28,424 - $64,638
-3,800 Reduced 15.88%
20,125 $319,000
Q3 2019

Nov 13, 2019
BUY
$6.89 - $10.45 $31,521 - $47,808
4,575 Added 23.64%
23,925 $188,000
Q2 2019

Aug 07, 2019
BUY
$8.85 - $12.49 $171,247 - $241,681
19,350 New
19,350 $205,000

Others Institutions Holding PRTA

# of Institutions
182
Shares Held
42.7M
Call Options Held
77.7K
Put Options Held
92.7K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $940M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email